Treatment-resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined. Here, we review the current literature on the genetics of response to these treatment modalities. To...
Dissociative experiences are prevalent in young people, where they are associated with greater clinical severity of co-occurring difficulties and increased risk of self-harm and suicide. Recent research suggests transdiagnostic dissociation plays a role in the development and maintenance of mental health problems such as anxiety, depression and psychosis, and may therefore constitute a novel...
bioRxivJune 14, 2025Michael Gruenwald, Sebastien De Landtsheer, Thomas Huebl et al.
preprint
Psychological trauma is associated with significant alterations of biological functions and is correlated with epigenetic changes specifically of DNA methylation. Trauma therapy is aiming at relieving the impact of trauma and is in initial studies also correlated with changes in DNA methylation. In this study we explored the changes in whole blood DNA methylation of participants of a program...
This article analyses the diagnostic criteria for borderline personality disorder as defined in the 5th edition of Diagnostic and Statistical Manual of Mental Disorders and the 11th revision of International Classification of Diseases. The combination of categorical and dimensional diagnostic models improves its validity, which meets the needs of clinical practice. At the same time, the...
Abstract Depression and anxiety are disabling and high incidence mental disorders characterized by phenotypic heterogeneity. Currently available treatments show severe limitations. Thus, there is an urgent need for effective treatments in this population. In the search for novel rapid-acting antidepressants, the psychedelic psilocybin has emerged as a promising therapy in several clinical...
Na het voltooien van deze activiteit moeten deelnemers in staat zijn om: Het werkingsmechanisme, de farmacokinetiek en de farmacodynamiek van esketamine bij de behandeling van depressie te beschrijven. De werkzaamheid, doseringstrategieën en klinische overwegingen voor het gebruik van esketamine bij therapieresistente depressie en ernstige depressie met suïcidale ideatie te evalueren....
After completing this activity, participants should be able to: Describe the mechanism of action, pharmacokinetics, and pharmacodynamics of esketamine in the treatment of depression. Evaluate the efficacy, dosing strategies, and clinical considerations for using esketamine in treatment-resistant depression and major depression with suicidal ideation. Identify and manage common and serious...
Sexual and gender minority (SGM) individuals experience disproportionately high rates of depression, anxiety, trauma, and discrimination, yet remain underrepresented in psychedelic research. This prospective, naturalistic study explored the impact of an ayahuasca retreat experience on mental health, quality of life, and spiritual well-being among SGM participants. Nineteen individuals attending...
The full therapeutic potential of serotonergic psychedelics (SP) in treating neuropsychiatric disorders, such as depression and schizophrenia, is limited by possible adverse effects, including perceptual disturbances and psychosis, which require administration in controlled clinical environments. This study investigates the synergistic benefits of combining psilocybin (PSIL) with...
This review explores the effectiveness of mantra-based meditation (MBM) in enhancing emotional stability, reducing anxiety and improving quality of life (QoL).Drawing on data from randomized controlled trials (RCTs), meta-analyses and observational studies published in last 1 decade, the review synthesizes findings from diverse populations, including students, veterans, healthcare workers and...